Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nutex Health (NUTX) Cash from Operations (2016 - 2025)

Nutex Health's Cash from Operations history spans 16 years, with the latest figure at 70389000.0 for Q4 2025.

  • For Q4 2025, Cash from Operations rose 130250.0% year-over-year to 70389000.0; the TTM value through Dec 2025 reached 248125000.0, up 971.68%, while the annual FY2025 figure was 248125000.0, 971.68% up from the prior year.
  • Cash from Operations for Q4 2025 was 70389000.0 at Nutex Health, down from 99514000.0 in the prior quarter.
  • Across five years, Cash from Operations topped out at 103321545.0 in Q2 2021 and bottomed at 7301945.0 in Q3 2022.
  • The 5-year median for Cash from Operations is 10024000.0 (2024), against an average of 24828729.7.
  • The largest annual shift saw Cash from Operations crashed 139.41% in 2023 before it surged 130250.0% in 2025.
  • A 5-year view of Cash from Operations shows it stood at 46424148.0 in 2021, then tumbled by 90.29% to 4505994.0 in 2022, then plummeted by 139.41% to 1775670.0 in 2023, then surged by 103.04% to 54000.0 in 2024, then soared by 130250.0% to 70389000.0 in 2025.
  • Per Business Quant, the three most recent readings for NUTX's Cash from Operations are 70389000.0 (Q4 2025), 99514000.0 (Q3 2025), and 27257000.0 (Q2 2025).